![Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments](https://www.frontiersin.org/files/MyHome%20Article%20Library/572329/572329_Thumb_400.jpg)
Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
![Coronavirus SARS-CoV-2 and the COVID-19 Pandemic: What is it and how does it spread? | Oklahoma State University Coronavirus SARS-CoV-2 and the COVID-19 Pandemic: What is it and how does it spread? | Oklahoma State University](https://extension.okstate.edu/fact-sheets/images/coronavirus-sars-cov-2-and-the-covid-19-pandemic-what-is-it-and-how-does-it-spread/fig2-covid.jpg)
Coronavirus SARS-CoV-2 and the COVID-19 Pandemic: What is it and how does it spread? | Oklahoma State University
![SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection | Science Immunology SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abd6160/asset/eb7b2def-7ffd-4f91-9328-8e67a723a5fe/assets/graphic/abd6160-f1.jpeg)
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection | Science Immunology
![Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection | Clinical Microbiology Reviews Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/cmr.00133-20/asset/d367ccbe-9ab9-4f52-99dc-afc543f9ff28/assets/graphic/cmr.00133-20-f0001.jpeg)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection | Clinical Microbiology Reviews
![Immuno | Free Full-Text | Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools Immuno | Free Full-Text | Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools](https://www.mdpi.com/immuno/immuno-02-00022/article_deploy/html/images/immuno-02-00022-g001.png)
Immuno | Free Full-Text | Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools
![Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses - Georgia State University News - Coronavirus Research, Faculty, Institute for Biomedical Sciences, Press Releases, Research, University Research - Health & Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses - Georgia State University News - Coronavirus Research, Faculty, Institute for Biomedical Sciences, Press Releases, Research, University Research - Health &](https://news.gsu.edu/files/2020/03/coronavirus1.jpg)
Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses - Georgia State University News - Coronavirus Research, Faculty, Institute for Biomedical Sciences, Press Releases, Research, University Research - Health &
![Aspectos generales sobre la estructura del coronavirus del síndrome respiratorio agudo grave 2 (SARS-CoV-2) Aspectos generales sobre la estructura del coronavirus del síndrome respiratorio agudo grave 2 (SARS-CoV-2)](http://scielo.sld.cu/img/revistas/ibi/v39n3//1561-3011-ibi-39-03-e867-gf1.jpg)
Aspectos generales sobre la estructura del coronavirus del síndrome respiratorio agudo grave 2 (SARS-CoV-2)
![Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe](https://www.thelancet.com/cms/attachment/c8b82db5-eaf0-44eb-b255-b88063a5079d/gr1_lrg.jpg)
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe
![SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420302294-fx1.jpg)